CJC-1295 and Hexarelin are both Growth Hormone peptides, but they're studied for different things. In short, CJC-1295 is a growth-hormone-releasing hormone analog studied for GH support, while Hexarelin is a potent GH secretagogue also studied for cardiac tissue effects. This page compares the two side by side — what each is researched for, how mature the evidence is, and how they're typically used — so you can see where they overlap and where they differ. It's educational information only, not medical advice, and neither is a substitute for a conversation with a licensed professional.
CJC-1295 vs Hexarelin at a glance
| CJC-1295 | Hexarelin | |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| In short | A growth-hormone-releasing hormone analog studied for GH support. | A potent GH secretagogue also studied for cardiac tissue effects. |
| Researched for | Growth hormone release, Body composition, Recovery & sleep | Growth hormone release, Cardiac tissue studies, Recovery |
| Research status | Some human pharmacology studies; not an approved therapy. | Preclinical and early human research. |
| Typically stacked with | Ipamorelin | CJC-1295 |
| Key consideration | Affects the endocrine system. Research use only in most regions. | Potency may lead to receptor desensitization. Endocrine-active. |
How does CJC-1295 work?
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It stimulates the pituitary to release the body's own growth hormone in a more sustained way, and is often researched together with a ghrelin-type secretagogue for a more pulsatile release pattern.
How does Hexarelin work?
Hexarelin is a potent growth-hormone-releasing peptide. Beyond stimulating GH, research has examined direct effects on cardiac tissue through the CD36 and ghrelin receptors, making it of interest in cardiovascular studies.
CJC-1295 vs Hexarelin: how to choose
Choosing between CJC-1295 and Hexarelin really comes down to your specific goal — and it's a decision for you and a licensed professional, not something to settle from a web page. CJC-1295 is most associated with Growth hormone release and Body composition, while Hexarelin leans toward Growth hormone release and Cardiac tissue studies. Where they overlap, the practical differences are usually in mechanism and how far the research has actually progressed. The two are also commonly discussed together as a stack rather than as either/or. Selpho provides no dosing or protocols; if you'd like a research-backed steer for your goals, the free Peptide Advisor is a good starting point.
Frequently asked questions
Both are Growth Hormone peptides. CJC-1295 is a growth-hormone-releasing hormone analog studied for GH support; Hexarelin is a potent GH secretagogue also studied for cardiac tissue effects. They're most researched for Growth hormone release, Body composition (CJC-1295) and Growth hormone release, Cardiac tissue studies (Hexarelin), respectively.
There's no universal "better" — it depends on your goal, and for most of these compounds robust head-to-head human evidence doesn't exist. The right choice is one made with a licensed professional. Selpho does not rank or prescribe; it offers educational information and a research-backed advisor.
CJC-1295 and Hexarelin are commonly discussed together as a stack in the research and community, based on complementary mechanisms. Selpho provides no dosing or protocols — any combination should only be considered with a licensed professional.
CJC-1295: Some human pharmacology studies; not an approved therapy. Hexarelin: Preclinical and early human research.
Not sure which fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis comparison is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.